Literature DB >> 30269654

Completeness and correctness of acute myocardial infarction diagnoses in a medical quality register and an administrative health register.

Ragna Elise Støre Govatsmark1,2, Imre Janszky1,3, Stig Arild Slørdahl2,4, Marta Ebbing5, Rune Wiseth6,7, Bjørnar Grenne6,7, Elisabeth Vesterbekkmo6, Kaare Harald Bønaa2,6,7,8.   

Abstract

Aims: Health registers are used for administrative purposes, disease surveillance, quality assessment, and research. The value of the registers is entirely dependent on the quality of their data. The aim of this study was to investigate and compare the completeness and correctness of the acute myocardial infarction (AMI) diagnosis in the Norwegian Myocardial Infarction Register and in the Norwegian Patient Register.
Methods: All Norwegian patients admitted directly to St Olavs hospital, Trondheim University Hospital, Trondheim University Hospital from 1 July to 31 December 2012 and who had plasma levels of cardiac troponin T measured during their hospitalization (n=4835 unique individuals, n=5882 hospitalizations) were identified in the hospital biochemical database. A gold standard for AMI was established by evaluation of maximum troponin T levels and by review of the information in the medical records. Cases of AMI in the registers were classified as true positive, false positive, true negative, and false negative according to the gold standard. We calculated sensitivity, positive predictive value (PPV), specificity, and negative predictive value (NPV).
Results: The Norwegian Myocardial Infarction Register had a sensitivity of 86.0% (95% confidence interval (CI) 82.8-89.3%), PPV of 97.9% (96.4-99.3%), and specificity of 99.9% and NPV of 98.9% (98.6-99.2%) (99.8-100%). The corresponding figures for the Norwegian Patient Register were 85.8% (95% CI 82.5-89.1%), 95.1% (92.9-97.2%), and 99.7% (99.5-99.8%) and 98.9% (98.6-99.2%), respectively. Both registers had a sensitivity higher than 95% when compared to hospital discharge diagnoses. The results were similar for men and women and for cases below and above 80 years of age. Conclusions: The Norwegian Myocardial Infarction Register and the Norwegian Patient Register are adequately complete and correct for administrative purposes, disease surveillance, quality assessment, and research.

Entities:  

Keywords:  Completeness; administrative register; correctness; data quality; health register; hospital discharge register; medical quality register; myocardial infarction; validity

Mesh:

Year:  2018        PMID: 30269654     DOI: 10.1177/1403494818803256

Source DB:  PubMed          Journal:  Scand J Public Health        ISSN: 1403-4948            Impact factor:   3.021


  12 in total

1.  Sex-related differences in the management and outcomes of patients hospitalized with ST-elevation myocardial infarction: a comparison within four European myocardial infarction registries.

Authors:  Tora Hellgren; Mai Blöndal; Jarle Jortveit; Tamas Ferenci; Jonas Faxén; Christian Lewinter; Jaan Eha; Piret Lõiveke; Toomas Marandi; Tiia Ainla; Aet Saar; Gudrun Veldre; Péter Andréka; Sigrun Halvorsen; András Jánosi; Robert Edfors
Journal:  Eur Heart J Open       Date:  2022-07-02

2.  Does a Code for Acute Myocardial Infarction Mean the Same in All Norwegian Hospitals? A Likelihood Approach to a Medical Record Review.

Authors:  Jon Helgeland; Doris Tove Kristoffersen; Katrine Damgaard Skyrud
Journal:  Clin Epidemiol       Date:  2022-10-13       Impact factor: 5.814

3.  Systematic assessment of prescribed medications and short-term risk of myocardial infarction - a pharmacopeia-wide association study from Norway and Sweden.

Authors:  Abhijit Sen; Ioannis Vardaxis; Bo Henry Lindqvist; Ben Michael Brumpton; Linn Beate Strand; Inger Johanne Bakken; Lars Johan Vatten; Pål Richard Romundstad; Rickard Ljung; Kenneth Jay Mukamal; Imre Janszky
Journal:  Sci Rep       Date:  2019-06-04       Impact factor: 4.379

4.  Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease.

Authors:  Jarle Jortveit; Sigrun Halvorsen; Anete Kaldal; Are Hugo Pripp; Ragna Elise S Govatsmark; Jørund Langørgen
Journal:  BMC Cardiovasc Disord       Date:  2019-03-28       Impact factor: 2.298

5.  Influenza vaccination and risk for cardiovascular events: a nationwide self-controlled case series study.

Authors:  Abhijit Sen; Inger Johanne Bakken; Ragna Elise Støre Govatsmark; Torunn Varmdal; Kaare Harald Bønaa; Kenneth Jay Mukamal; Siri Eldevik Håberg; Imre Janszky
Journal:  BMC Cardiovasc Disord       Date:  2021-01-13       Impact factor: 2.298

6.  Time-to-pregnancy and risk of cardiovascular disease among men and women.

Authors:  Maria C Magnus; Abigail Fraser; Janet W Rich-Edwards; Per Magnus; Deborah A Lawlor; Siri E Håberg
Journal:  Eur J Epidemiol       Date:  2021-01-25       Impact factor: 12.434

7.  Validating Acute Myocardial Infarction Diagnoses in National Health Registers for Use as Endpoint in Research: The Tromsø Study.

Authors:  Torunn Varmdal; Ellisiv B Mathiesen; Tom Wilsgaard; Inger Njølstad; Audhild Nyrnes; Sameline Grimsgaard; Kaare Harald Bønaa; Jan Mannsverk; Maja-Lisa Løchen
Journal:  Clin Epidemiol       Date:  2021-08-03       Impact factor: 4.790

8.  Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention.

Authors:  Mari Nordbø Gynnild; Steven H J Hageman; Jannick A N Dorresteijn; Olav Spigset; Stian Lydersen; Torgeir Wethal; Ingvild Saltvedt; Frank L J Visseren; Hanne Ellekjær
Journal:  Clin Epidemiol       Date:  2021-09-17       Impact factor: 4.790

9.  A nationwide registry study on heart failure in Norway from 2008 to 2018: variations in lookback period affect incidence estimates.

Authors:  Kristina Malene Ødegaard; Sandre Svatun Lirhus; Hans Olav Melberg; Jonas Hallén; Sigrun Halvorsen
Journal:  BMC Cardiovasc Disord       Date:  2022-03-05       Impact factor: 2.298

10.  The rise in the number of long-term survivors from different diseases can slow the increase in life expectancy of the total population.

Authors:  Marcus Ebeling; Anna C Meyer; Karin Modig
Journal:  BMC Public Health       Date:  2020-10-07       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.